Sato Ayuko Department
Hyogo Medical University(Specialty Division)
Pathology Division of Molecular Pathology, Seminars of Clinico-Basic Integrative Medicine
Hyogo Medical University(Corporation/Other Facilities)
Surgical Pathology, Central Clinic
Position
■ Journal
1.
Original article
p53-Dependent suppression of genome instability in germ cells. 2014/02
2.
Original article
Exposure to High Doses of Lipopolysaccharide during Ovalbumin Sensitization Prevents the Development of Allergic Th2 Responses to a Dietary Antigen. 2014/10
3.
Original article
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
4.
Original article
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. 2015/01
5.
Original article
Biallelic germline and somatic mutations in malignant mesothelioma: Multiple mutations in transcription regulators including mSWI/SNF genes. 2015/02
6.
Original article
Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level. 2015/08
7.
Original article
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. 2016/09
8.
Original article
BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests. 2016/10
9.
Original article
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. 2016/11
10.
Original article
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry. 2017/02
11.
Original article
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. 2017/02
12.
Original article
The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis. 2017/09
13.
Original article
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. 2018/01
14.
Original article
Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. 2018/07
15.
Original article
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. 2018/11
16.
Original article
Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma. 2019/07
17.
Original article
Involvement of Rev1 in alkylating agent-induced loss of heterozygosity in Oryzias latipes. 2020/02
18.
Original article
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma. 2020/08
19.
Original article
Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma. 2020/09
20.
Original article
Utility of highly expressed EZH2 in pleural effusion cytology for the diagnosis of mesothelioma. 2020/10
21.
Original article
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1. 2021/03
22.
Original article
Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma. 2021/07
23.
Original article
Short 57 kb CDKN2A FISH probe effectively detects short homozygous deletion of the 9p21 locus in malignant pleural mesothelioma. 2021/12
24.
Original article
Enhancement of Regnase-1 expression with stem loop-targeting antisense oligonucleotides alleviates inflammatory diseases. 2022/05
25.
Original article
Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. 2022/06
26.
Original article
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
27.
Original article
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages. 2022/09
28.
Original article
Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study. 2022/11
29.
Original article
Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations. 2023/06
Pathology of Mesothelioma, Subtypes, and Rare Variants: What Is the Role of Immunohistochemical Markers in Differential Diagnosis?, Malignant Pleural Mesothelioma Advances in Pathogenesis, Diagnosis, and Treatments 2021/02
■ Presentation
1.
Biological roles of deletion of PBRM1 and BAP1 in malignant mesotheliomas (Oral presentation,General Lecture) 2013/10/03
Rare germline variants of transcription regulator genes in malignant mesothelioma (Poster presentation,General Lecture) 2014/09/27
4.
CD146 expression is associated with prognosis of malignant mesothelioma (Poster presentation,General Lecture) 2014/10/23
5.
Relationship of PD-L1 Expression and Prognosis in Epithelioid Mesothelioma (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/03
6.
BAP1 immunostaining and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/29
7.
Clinial, Cytological, and Molecular biological approaches to the diagnosis of early mesothelopma (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/05/29
8.
Utility of liquid-based cytology in the diagnosis of malignant pleural mesothelioma (Poster presentation,General Lecture) 2016/05/29
The role of EZH2 in the proliferation, migration, and tumorigenicity of malignant mesothelioma. (Poster presentation,General Lecture) 2018/05/03
11.
Immunohistochemical detection of MTAP or BAP1 protein loss in tissues and cell blocks for diagnosis of mesothelioma. (Poster presentation,General Lecture) 2018/05/05